Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't effectively treat hair loss in postmenopausal women.

The painting of an 18th-century Sicilian baroness shows she had hair loss, possibly due to ovarian issues, insulin resistance, or a specific type of tumor.

The document's conclusion cannot be provided as the content is not available for parsing.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Ovarian stromal tumors are a rare cause of women developing male characteristics after menopause.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

The document did not provide enough information to summarize the causes of hair loss in pre- and postmenopausal women.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Melatonin treatment helps improve skin health in postmenopausal rats.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.